KemPharm Inc. (KMPH) Dropped To A New Low After FDA Complete Response Letter

KemPharm Inc. (KMPH) announced after the bell Monday that it has received a complete response letter from the FDA regarding its New Drug Application for Apadaz.

from RTT - Before the Bell http://ift.tt/1PtxbDC
via IFTTT